FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213310740> ?p ?o ?g. }

• W3213310740 endingPage "415" @default.
• W3213310740 startingPage "406" @default.
• W3213310740 abstract "Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, delayed hypersensitivity reaction (DHR). We observed DRESS to inhibitors of interleukin 1 (IL-1) or IL-6 in a small group of patients with Still's disease with atypical lung disease. We sought to characterise features of patients with Still's disease with DRESS compared with drug-tolerant Still's controls. We analysed human leucocyte antigen (HLA) alleles for association to inhibitor-related DHR, including in a small Kawasaki disease (KD) cohort.In a case/control study, we collected a multicentre series of patients with Still's disease with features of inhibitor-related DRESS (n=66) and drug-tolerant Still's controls (n=65). We retrospectively analysed clinical data from all Still's subjects and typed 94/131 for HLA. European Still's-DRESS cases were ancestry matched to International Childhood Arthritis Genetics Consortium paediatric Still's cases (n=550) and compared for HLA allele frequencies. HLA association also was analysed using Still's-DRESS cases (n=64) compared with drug-tolerant Still's controls (n=30). KD subjects (n=19) were similarly studied.Still's-DRESS features included eosinophilia (89%), AST-ALT elevation (75%) and non-evanescent rash (95%; 88% involving face). Macrophage activation syndrome during treatment was frequent in Still's-DRESS (64%) versus drug-tolerant Still's (3%; p=1.2×10-14). We found striking enrichment for HLA-DRB1*15 haplotypes in Still's-DRESS cases versus INCHARGE Still's controls (p=7.5×10-13) and versus self-identified, ancestry-matched Still's controls (p=6.3×10-10). In the KD cohort, DRB1*15:01 was present only in those with suspected anakinra reactions.DRESS-type reactions occur among patients treated with IL-1/IL-6 inhibitors and strongly associate with common HLA-DRB1*15 haplotypes. Consideration of preprescription HLA typing and vigilance for serious reactions to these drugs are warranted." @default.
• W3213310740 created "2021-11-22" @default.
• W3213310740 creator A5012264707 @default.
• W3213310740 creator A5013648604 @default.
• W3213310740 creator A5013771571 @default.
• W3213310740 creator A5015600871 @default.
• W3213310740 creator A5016268217 @default.
• W3213310740 creator A5017214251 @default.
• W3213310740 creator A5017327198 @default.
• W3213310740 creator A5020348954 @default.
• W3213310740 creator A5027023803 @default.
• W3213310740 creator A5028993634 @default.
• W3213310740 creator A5033912225 @default.
• W3213310740 creator A5034696730 @default.
• W3213310740 creator A5037514446 @default.
• W3213310740 creator A5041988687 @default.
• W3213310740 creator A5043100489 @default.
• W3213310740 creator A5046168311 @default.
• W3213310740 creator A5052532450 @default.
• W3213310740 creator A5065297743 @default.
• W3213310740 creator A5066851751 @default.
• W3213310740 creator A5067676916 @default.
• W3213310740 creator A5070152563 @default.
• W3213310740 creator A5072539940 @default.
• W3213310740 creator A5077699690 @default.
• W3213310740 creator A5080992616 @default.
• W3213310740 creator A5083404464 @default.
• W3213310740 creator A5088917579 @default.
• W3213310740 creator A5089958351 @default.
• W3213310740 date "2021-11-17" @default.
• W3213310740 modified "2023-10-18" @default.
• W3213310740 title "Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles" @default.
• W3213310740 cites W1709111196 @default.
• W3213310740 cites W1975696393 @default.
• W3213310740 cites W1990180387 @default.
• W3213310740 cites W2010387075 @default.
• W3213310740 cites W2033654955 @default.
• W3213310740 cites W2066724445 @default.
• W3213310740 cites W2087769239 @default.
• W3213310740 cites W2089378839 @default.
• W3213310740 cites W2090134611 @default.
• W3213310740 cites W2091933756 @default.
• W3213310740 cites W2102207725 @default.
• W3213310740 cites W2105211030 @default.
• W3213310740 cites W2168850597 @default.
• W3213310740 cites W2175199415 @default.
• W3213310740 cites W2179196974 @default.
• W3213310740 cites W2263588119 @default.
• W3213310740 cites W2324667434 @default.
• W3213310740 cites W2415396904 @default.
• W3213310740 cites W2555499273 @default.
• W3213310740 cites W2608171249 @default.
• W3213310740 cites W2611564992 @default.
• W3213310740 cites W2891385015 @default.
• W3213310740 cites W2922158322 @default.
• W3213310740 cites W2941577943 @default.
• W3213310740 cites W2946860347 @default.
• W3213310740 cites W2963476527 @default.
• W3213310740 cites W2973040963 @default.
• W3213310740 cites W2974966193 @default.
• W3213310740 cites W2990440465 @default.
• W3213310740 cites W3002457465 @default.
• W3213310740 cites W3005968092 @default.
• W3213310740 cites W3010703220 @default.
• W3213310740 cites W3014729980 @default.
• W3213310740 cites W3033922735 @default.
• W3213310740 cites W3094199989 @default.
• W3213310740 cites W3112902030 @default.
• W3213310740 cites W3113319576 @default.
• W3213310740 cites W3167694762 @default.
• W3213310740 doi "https://doi.org/10.1136/annrheumdis-2021-220578" @default.
• W3213310740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34789453" @default.
• W3213310740 hasPublicationYear "2021" @default.
• W3213310740 type Work @default.
• W3213310740 sameAs 3213310740 @default.
• W3213310740 citedByCount "33" @default.
• W3213310740 countsByYear W32133107402021 @default.
• W3213310740 countsByYear W32133107402022 @default.
• W3213310740 countsByYear W32133107402023 @default.
• W3213310740 crossrefType "journal-article" @default.
• W3213310740 hasAuthorship W3213310740A5012264707 @default.
• W3213310740 hasAuthorship W3213310740A5013648604 @default.
• W3213310740 hasAuthorship W3213310740A5013771571 @default.
• W3213310740 hasAuthorship W3213310740A5015600871 @default.
• W3213310740 hasAuthorship W3213310740A5016268217 @default.
• W3213310740 hasAuthorship W3213310740A5017214251 @default.
• W3213310740 hasAuthorship W3213310740A5017327198 @default.
• W3213310740 hasAuthorship W3213310740A5020348954 @default.
• W3213310740 hasAuthorship W3213310740A5027023803 @default.
• W3213310740 hasAuthorship W3213310740A5028993634 @default.
• W3213310740 hasAuthorship W3213310740A5033912225 @default.
• W3213310740 hasAuthorship W3213310740A5034696730 @default.
• W3213310740 hasAuthorship W3213310740A5037514446 @default.
• W3213310740 hasAuthorship W3213310740A5041988687 @default.
• W3213310740 hasAuthorship W3213310740A5043100489 @default.
• W3213310740 hasAuthorship W3213310740A5046168311 @default.
• W3213310740 hasAuthorship W3213310740A5052532450 @default.
• W3213310740 hasAuthorship W3213310740A5065297743 @default.

• next